Denise Treue

6PUBLICATIONS
47CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 05, 2024
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials.

Paul Jank, Thomas Karn, Marion van Mackelenbergh

|Feb 17, 2021
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer.

Bruno V Sinn, Sibylle Loibl, Claus A Hanusch

|May 30, 2020
Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.

Clemens Messerschmidt, Benedikt Obermayer, Konrad Klinghammer

|Apr 03, 2020
TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial.

Marianne Sinn, Bruno V Sinn, Denise Treue

|Sep 13, 2019
Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases.

Philipp Jurmeister, Michael Bockmayr, Philipp Seegerer

|Sep 06, 2018
Proteogenomic systems analysis identifies targeted therapy resistance mechanisms in EGFR-mutated lung cancer.

Denise Treue, Michael Bockmayr, Albrecht Stenzinger

Pageof 1

Frequent Collaborators

3 joint publications

Marianne Sinn

3 joint publications

Carsten Denkert

2 joint publications

Albrecht Stenzinger

2 joint publications

Peter Fasching